Your browser doesn't support javascript.
loading
Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations.
Liu, Di; Cao, Meiling; Wang, Haotian; Cao, Weijie; Zheng, Chenguang; Li, Yun; Wang, Youxin.
Affiliation
  • Liu D; Centre for Biomedical Information Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
  • Cao M; Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, 100069, China.
  • Wang H; Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, 100069, China.
  • Cao W; Centre for Precision Medicine, Edith Cowan University, Perth, WA7027, Australia.
  • Zheng C; School of Public Health, North China University of Science and Technology, Tangshan, 063210, China.
  • Li Y; School of Public Health, North China University of Science and Technology, Tangshan, 063210, China.
  • Wang Y; Centre for Precision Medicine, Edith Cowan University, Perth, WA7027, Australia. wangyouxin@ncst.edu.cn.
BMC Med ; 22(1): 137, 2024 Mar 25.
Article in En | MEDLINE | ID: mdl-38528540
ABSTRACT

BACKGROUND:

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), has been associated with several cancer risks in observational studies, but the observed associations have been inconsistent and may face the bias of confounding and reverse causality. The potential causal relationships between IBD and the risk of cancers remain largely unclear.

METHODS:

We performed genome-wide linkage disequilibrium score regression (LDSC), standard two-sample Mendelian randomization (MR), and colocalization analyses using summary genome-wide association study (GWAS) data across East Asian and European populations to evaluate the causal relationships between IBD and cancers. Sensitivity analyses for the MR approach were additionally performed to explore the stability of the results.

RESULTS:

There were no significant genetic correlations between IBD, CD, or UC and cancers (all P values > 0.05) in East Asian or European populations. According to the main MR analysis, no significant causal relationship was observed between IBD and cancers in the East Asian population. There were significant associations between CD and ovarian cancer (odds ratio [OR] = 0.898, 95% CI = 0.844-0.955) and between UC and nonmelanoma skin cancer (OR = 1.002, 95% CI = 1.000-1.004, P = 0.019) in the European population. The multivariable MR analysis did not find any of the above significant associations. There was no shared causal variant to prove the associations of IBD, CD, or UC with cancers in East Asian or European populations using colocalization analysis.

CONCLUSIONS:

We did not provide robust genetic evidence of causal associations between IBD and cancer risk. Exposure to IBD might not independently contribute to the risk of cancers, and the increased risk of cancers observed in observational studies might be attributed to factors accompanying the diagnosis of IBD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Limits: Female / Humans Language: En Journal: BMC Med / BMC med / BMC medicine Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Limits: Female / Humans Language: En Journal: BMC Med / BMC med / BMC medicine Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: China